First published 9/30/2026, 10:59:15 AM · Last updated 9/30/2026, 10:59:15 AM

Rutin ameliorates perioperative neurocognitive disorders by inhibiting microglial HIF-1α/PKM2‑driven glycolysis

A journal article (Publisher: Elsevier BV) published 2026-10-01 reports that rutin ameliorates perioperative neurocognitive disorders by inhibiting microglial HIF-1α/PKM2-driven glycolysis. Additional experimental details, population scope, and outcomes were not included in the supplied source data.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 4/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article reports a potential therapeutic effect of rutin on perioperative neurocognitive disorders, indicating scientific and clinical relevance.

Sources

Rutin ameliorates perioperative neurocognitive disorders by inhibiting microglial HIF-1α/PKM2‑driven glycolysis

Report an issue